The largest opportunity for the growth of Brintellix comes from Dr. Mood and Dr. Function. In this podcast, we get familiar with the target segments that will lead to the success of our strategic brand plan. After looking at more than 800 HCPs, the research data offers insights to gain a deeper understanding of who is at the other end of a sales call. We explain why our focus is on low and medium prescribers and the crucial importance of maintaining our relationship with the high-prescribing, Dr. Progressive.
Key Takeaways:
[2:28] Understanding how Dr. Mood evaluates a MDD patient's symptoms and the prescription driver that can increase their use of Brintellix to improve more symptoms.
[4:46] Understanding Dr. Function's treatment goals when they typically believe there is no current treatment option.
[7:46] How to maintain the established relationship with the high-prescriber, Dr. Progressive, and the crucial information they need to expand their Brintellix/Vortioxetine prescriptions.
[10:42] How to identify segment types when a rep is opening up a call with HCPs.
Resources:
